Discontinuation of anti-PD-1 antibody therapy in the absence of disease progression or treatment limiting toxicity: clinical outcomes in advanced melanoma

Jansen, Y.J.L. ; Rozeman, E.A. ; Mason, R. ; Goldinger, S.M. ; Geukes Foppen, M.H. ; Hoejberg, L. ; Schmidt, H. ; van Thienen, J.V. ; Haanen, J.B.A.G. ; Tiainen, L. ; Svane, I.M. ; Mäkelä, S. ; Seremet, T. ; Arance, A. ; Dummer, R. ; Bastholt, L. ; Nyakas, M. ; Straume, O. ; Menzies, A.M. ; Long, G.V. ; Atkinson, V. ; Blank, C.U. ; Neyns, B.

Annals of oncology, 2019-07, Vol.30 (7), p.1154-1161 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível